radiolabeled AZ-093 (Five Eleven Pharma/University of Pennsylvania)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameradiolabeled AZ-093 (Five Eleven Pharma/University of Pennsylvania)
Drug Alias Nameprostate-specific membrane antigen targeting radiotheranostic (Five Eleven Pharma/University of Pennsylvania)[177Lu]-AZ-093AZ-093-[68Ga]AZ-093-177LuGallium-68-AZ-093 +[10] 
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radioactive therapeutic agent +[4] 
Mechanisms of ActionProstate-Specific Membrane Antigen modulators
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Active CompaniesFive Eleven Pharma IncUniversity Of Pennsylvania
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A